Surgical Outcomes of Modified CO
CO2 laser
Nonpenetrating deep sclerectomy
intraocular pressure
surgical management
uveitic glaucoma
Journal
Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169
Informations de publication
Date de publication:
Historique:
pubmed:
14
5
2021
medline:
15
12
2022
entrez:
13
5
2021
Statut:
ppublish
Résumé
To evaluate the clinical safety and efficacy of modified CO This retrospective study included UG and POAG patients from the modified CLASS Study Group database. Intraocular pressure (IOP) and the number of glaucoma medications were compared between groups by the Wilcoxon test. The Kaplan-Meier method was used for survival analysis; complete success was defined as 5≤ IOP≤18 mmHg and a ≥ 20% reduction in IOP from baseline without medication. Twenty-three and 25 eyes in UG and POAG groups were included. At the 12-month visit in both groups, the mean IOP and mean number of IOP-lowering medications were significantly reduced compared to baseline, with complete success rates of 60.9% and 64.0% in the UG and POAG groups ( Modified CLASS yields similar outcomes for patients with UG and POAG.
Identifiants
pubmed: 33983863
doi: 10.1080/09273948.2021.1924385
doi:
Substances chimiques
Carbon Dioxide
142M471B3J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM